In vivo effects of AZD4547, a novel fibroblast growth factor receptor inhibitor, in a mouse model of endometriosis
Abstract Endometriosis is a chronic disease, characterized by the growth of endometrial‐like cells outside the uterine cavity. Due to its complex pathophysiology, a totally resolving cure is yet to be found. The aim of this study was to compare the therapeutic efficacy of AZD4547, a novel fibroblast...
Main Authors: | Sara Santorelli, Deborah P. Fischer, Michael K. Harte, Johanna Laru, Kay M. Marshall |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-04-01
|
Series: | Pharmacology Research & Perspectives |
Subjects: | |
Online Access: | https://doi.org/10.1002/prp2.759 |
Similar Items
-
Use of dienogest in endometriosis. A narrative literature review and expert commentary
by: Ally Murji, et al.
Published: (2020-05-01) -
Medical Treatment for Endometriosis: Tolerability, Quality of Life and Adherence
by: Giussy Barbara, et al.
Published: (2021-09-01) -
Aspectos atuais do diagnóstico e tratamento da endometriose Current aspects on diagnosis and treatment of endometriosis
by: Andrea Prestes Nácul, et al.
Published: (2010-06-01) -
Role of suppression of endometriosis with progestins before IVF-ET: a non-inferiority randomized controlled trial
by: Eissa Khalifa, et al.
Published: (2021-03-01) -
In situ imaging of quantum dot-AZD4547 conjugates for tracking the dynamic behavior of fibroblast growth factor receptor 3
by: Hwang G, et al.
Published: (2017-07-01)